Louis Vermeulen
Overview
Explore the profile of Louis Vermeulen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
9801
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Linssen J, Schafrat P, de Back T, van Erning F, van Leerdam M, Dekker E, et al.
Int J Cancer
. 2025 Feb;
PMID: 39907526
Small intestinal adenocarcinomas (SIAs) are associated with predisposing conditions, including inflammatory bowel disease (IBD) and celiac disease, but also genetic syndromes such as Lynch syndrome (LS) and familial adenomatous polyposis...
3.
Abidi S, Chan S, Seidel K, Lafkas D, Vermeulen L, Peale F, et al.
Elife
. 2024 Nov;
13.
PMID: 39585329
The sebaceous gland (SG) is a vital appendage of the epidermis, and its normal homeostasis and function is crucial for effective maintenance of the skin barrier. Notch signaling is a...
4.
Schwarzmueller L, Adam R, Moreno L, Nijman L, Logiantara A, Eleonora S, et al.
Gut
. 2024 Nov;
74(4):571-585.
PMID: 39562049
Background: Aberrant Wnt pathway activation is a key driver of colorectal cancer (CRC) and is essential to sustain tumour growth and progression. Although the downstream protein-coding target genes of the...
5.
Saris J, Bootsma S, Verhoeff J, Tuynman J, Wildenberg M, Rijnstra E, et al.
Front Immunol
. 2024 Jul;
15:1415457.
PMID: 39044825
Background: The occurrence of peritoneal metastasis (PM) in patients with colorectal cancer (CRC) has a dismal prognosis. There is often limited response to systemic- and immunotherapy, even in microsatellite unstable...
6.
de Back T, van Hooff S, Sommeijer D, Vermeulen L
Trends Cancer
. 2024 Jul;
10(9):842-856.
PMID: 39019673
Gastrointestinal (GI) cancers are highly heterogeneous at multiple levels. Tumor heterogeneity can be captured by molecular profiling, such as genetic, epigenetic, proteomic, and transcriptomic classification. Transcriptomic subtyping has the advantage...
7.
LaBella K, Reyes E, Vermeulen L
Cell Stem Cell
. 2024 Jul;
31(7):943-945.
PMID: 38971144
The differentiation trajectories defining enteroendocrine (EE) cell heterogeneity remain obscure. In this issue of Cell Stem Cell, Singh et al. map the differentiation landscape of EE cells, identifying early oscillating...
8.
de Back T, Wu T, Schafrat P, Ten Hoorn S, Tan M, He L, et al.
Life Sci Alliance
. 2024 Jun;
7(9).
PMID: 38936972
No abstract available.
9.
Fobian S, Mei X, Crezee J, Snoek B, Steenbergen R, Hu J, et al.
J Med Virol
. 2024 Jun;
96(6):e29741.
PMID: 38922964
Cervical cancer is the fourth most common cancer in women worldwide and is caused by persistent infection with high-risk types of human papillomavirus (HPV). HPV viral load, the amount of...
10.
de Back T, Wu T, Schafrat P, Ten Hoorn S, Tan M, He L, et al.
Life Sci Alliance
. 2024 May;
7(8).
PMID: 38782602
Consensus Molecular Subtype (CMS) classification of colorectal cancer (CRC) tissues is complicated by RNA degradation upon formalin-fixed paraffin-embedded (FFPE) preservation. Here, we present an FFPE-curated CMS classifier. The CMSFFPE classifier...